30 Women in Clinical Trials Receive 3D-Printed Breast Scaffolds
BellaSeno's clinical trials have involved 30 women receiving 3D-printed breast scaffolds made from bioresorbable materials, marking a step forward in reconstructive surgery.
BellaSeno, a medical technology company, has reported that 30 women have participated in its clinical trials using 3D-printed breast scaffolds. These scaffolds are designed to support tissue regeneration in breast reconstruction procedures.
The scaffolds are fabricated using bioresorbable materials, meaning they are designed to degrade naturally within the body over time as new tissue grows. This approach aims to provide a temporary structural framework that facilitates the body's own healing processes.
The trials are focused on evaluating the safety and efficacy of these 3D-printed scaffolds in reconstructive breast surgery. The technology offers a personalized approach, with scaffolds potentially being tailored to individual patient anatomy.
This development is part of ongoing research into additive manufacturing applications within the medical field, specifically for tissue engineering and regenerative medicine. The goal is to improve outcomes for patients undergoing reconstructive procedures.
BellaSeno's use of 3D-printed bioresorbable scaffolds represents an advancement in personalized reconstructive surgery. By providing a tailored, temporary support structure for tissue regeneration, this technology could enhance patient outcomes and reduce the need for permanent implants. It aligns with the broader trend of using additive manufacturing to create patient-specific medical devices and promote healing in complex anatomical areas.
Edited by the news editor with AI from the original report — please refer to the original source.